Available configurations
Each strength has a separate identifier so the selected material stays clear from the catalog through checkout.
- 80 mgPMR-KLOW-080
Researcher Verification
Laboratory research access
PepMedic Research products are intended exclusively for qualified laboratory research. Please confirm the statements below before continuing.
By entering, you acknowledge that products displayed here are labeled for research use only. This demo storefront does not provide medical advice.
Back to catalog
Research
PepMedic Research Product
KLOW
KLOW is cataloged by PepMedic Research in 80 mg configuration. This 80 mg multi-component research blend contains GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg, and KPV 10 mg in one cataloged configuration.
$89.99 single bottle
Checking current inventory…
Currently available in one strength.
For research only
This product is presented for laboratory research use only and is not intended for human or veterinary use.
Detailed Product Record
KLOW catalog information
KLOW is cataloged by PepMedic Research in 80 mg configuration. This 80 mg multi-component research blend contains GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg, and KPV 10 mg in one cataloged configuration. Current bottle availability is checked before an item can be added to an order. Sold exclusively for qualified laboratory research and not for human or veterinary use.
Ordering and traceability
Strength, package quantity, price, and SKU are carried into the cart and order record. Active products also use live bottle inventory to prevent unavailable quantities from being purchased.
Documentation status
Independent certificates of analysis will be linked by product and lot when available. For documentation questions, contact PepMedic with the product name, strength, and order number.
Contact PepMedic about documentationResearch-use scope
This catalog record is intended for qualified laboratory and in-vitro research. It does not provide medical advice, human-use instructions, treatment guidance, or dosing information.
Read the research-use policy